CIK 0001833769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,545
- in 2 filings
Net −$12,545. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Siddiqui Khan CMO and Chief Strategy Officer | Sale | −1,729 | $2.26 | $4K | 76,981 |
| 2023-07-24 | TEISSEYRE THOMAS Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-06-09 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +85,000 | 85,000 | ||
| 2023-06-09 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +85,000 | 85,000 | ||
| 2023-06-09 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Wolterman Dan Director | Grant or award · Stock Options (right to buy) | +85,000 | 85,000 | ||
| 2023-06-09 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Fattori Ruth A Director | Grant or award · Stock Options (right to buy) | +85,000 | 85,000 | ||
| 2023-06-09 | Dahldorf John T Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Dahldorf John T Director | Grant or award · Stock Options (right to buy) | +85,000 | 85,000 | ||
| 2023-06-09 | Huennekens R Scott Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-06-09 | Huennekens R Scott Director | Returned to the company · Stock Options (right to buy) | −237,437 | 0 | ||
| 2023-06-09 | Huennekens R Scott Director | Grant or award · Stock Option (right to buy) | +237,437 | 237,437 | ||
| 2023-06-09 | ROTHBERG JONATHAN M Director | Grant or award · Stock Options (right to buy) | +112,000 | 112,000 | ||
| 2023-05-23 | Siddiqui Khan See Remarks | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-05-16 | Siddiqui Khan CMO and Chief Strategy Officer | Sale | −1,735 | $1.25 | $2K | 78,710 |
| 2023-03-03 | Siddiqui Khan CMO and Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +368,400 | 368,400 | ||
| 2023-02-16 | Siddiqui Khan CMO and Chief Strategy Officer | Sale | −4,635 | $1.39 | $6K | 80,445 |
Page 3 of 8 · 149 trades